➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Baxter
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

Potassium chloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for potassium chloride and what is the scope of patent protection?

Potassium chloride is the generic ingredient in forty-four branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Glenmark Pharms Ltd, Lannett Co Inc, Lupin Ltd, Novel Labs Inc, Paddock Llc, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Pharma Res Software, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Icu Medical Inc, Apotex, Genus Lifesciences, Pharm Assoc, Future Pak, Abbvie, Apothecon, Ascent Pharms Inc, Aurobindo Pharma Ltd, Centaur Pharms Pvt, Copley Pharm, Granules, Granules Pharms, Mylan, Paddock Labs Llc, Schering, Sigmapharm Labs Llc, Vitruvias Therap, Yichang Humanwell, and Novartis, and is included in one hundred and nine NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and forty drug master file entries for potassium chloride. Eighty-three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for potassium chloride
Drug Prices for potassium chloride

See drug prices for potassium chloride

Drug Sales Revenue Trends for potassium chloride

See drug sales revenues for potassium chloride

Generic filers with tentative approvals for POTASSIUM CHLORIDE
Applicant Application No. Strength Dosage Form
  Start Trial  Start Trial20MEQTablet; Oral
  Start Trial  Start Trial10MEQTablet, Extended Release; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 206759-001 Aug 9, 2016 AB2 RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs KLOR-CON M20 potassium chloride TABLET, EXTENDED RELEASE;ORAL 074726-001 Nov 20, 1998 AB1 RX No Yes   Start Trial   Start Trial   Start Trial
Miles POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 080195-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 212861-002 May 8, 2020 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Kv Pharm MICRO-K LS potassium chloride FOR SUSPENSION, EXTENDED RELEASE;ORAL 019561-003 Aug 26, 1988   Start Trial   Start Trial
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-001 Jun 13, 1986   Start Trial   Start Trial
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-002 Jun 13, 1986   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.